Findings of post hoc analyses published in JAMA Ophthalmology suggest that preoperative Scheimpflug imaging can help predict corneal edema resolution following Descemet membrane endothelial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio There is a “wow” effect from refractive ...

Please provide your email address to receive an email when new articles are posted on . Topline results from a phase 1 extension study show EO2002, a nonsurgical cell therapy for corneal edema, ...

Company also completes Phase 1 epithelial study to evaluate the safety of topical TTHX1114 to reduce the duration and impact of corneal epithelial defects SAN DIEGO--(BUSINESS WIRE)--Trefoil ...

DelveInsight's Persistent Corneal Edema Market Insights report includes a comprehensive understanding of current treatment practices, persistent corneal edema emerging drugs, market share of ...

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Corneal Edema Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added ...

MENLO PARK, Calif., Sept. 22, 2020 /PRNewswire/ -- Emmetrope Ophthalmics LLC ("Emmecell"), a clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for ...

Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) is a revolutionary surgical procedure that allows replacement of the diseased endothelium in cases of endothelial corneal dystrophies ...

The Food and Drug Administration recently approved a new contact lens for the treatment of corneal edema —an eye condition that causes swelling, fluid build up, blurred vision, haziness and scarring.

Hazy vision is a symptom of corneal edema secondary to endothelial dysfunction. (Aurion Biotech Image) Aurion Biotech has raised $120 million to advance its cell therapy for an eye disorder that ...

The corneal edema market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of corneal edema in the US is expected to increase, driven by the launch ...

SAN DIEGO--(BUSINESS WIRE)--Trefoil Therapeutics, a clinical-stage biotechnology company focused on developing novel new therapeutic agents to treat corneal diseases, today announced a series of data ...